Viewing Study NCT06886659


Ignite Creation Date: 2025-12-24 @ 2:54 PM
Ignite Modification Date: 2025-12-24 @ 2:54 PM
Study NCT ID: NCT06886659
Status: COMPLETED
Last Update Posted: 2025-07-22
First Post: 2025-01-12
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study to Compare PK, Immunogenicity and Safety of Trastuzumab of Incepta Pharmaceuticals Ltd With Trastuzumab (Roche)
Sponsor: Incepta Pharmaceuticals Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module